# Summary of federal obligations for research and experimental development, by type of R&D and type of performer, for selected agencies: FYs 2019–21

**Modal ID:** 6133

**Table Number:** 1

**Type:** RH (Row Hierarchical)

**Units:** (Millions of current dollars and percent change)

## Notes

Because of rounding, details may not add to total. Percentages are computed using actual dollars reported. FYs 2020 and 2021 data include obligations from supplemental COVID-19–related appropriations (e.g., Coronavirus Aid, Relief, and Economic Security [CARES] Act). Federal intramural amounts for the Biomedical Advanced Research and Development Authority are transfers to the other agencies in support of Operation Warp Speed. FY 2021 data are preliminary.

## Sources

National Center for Science and Engineering Statistics, Survey of Federal Funds for Research and Development.

## Files

- `data.csv`: The table data in CSV format
- `croissant_metadata.json`: ML Croissant metadata for machine learning applications

## Structure

- Row hierarchy depth: 5
- Column hierarchy depth: 1
- Time series: No

## Special Values

- `i`: imputed value
- `r`: revised value
- `D`: suppressed to avoid disclosure of confidential information
